Evidence map›Paper›PMID 30006635›Full record

ArticleScientific reports2018

Hemostatic nanoparticles increase survival, mitigate neuropathology and alleviate anxiety in a rodent blast trauma model.

W Brad Hubbard, Margaret Lashof-Sullivan, Shaylen Greenberg, Carly Norris, Joseph Eck, Erin Lavik, Pamela VandeVord

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Article
  3. Transfusion biomaterials for hemostasis.Journal of thrombosis and haemostasis : JTH · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. ENGINEERED INTRAVENOUS THERAPIES FOR TRAUMA.Current opinion in biomedical engineering · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Biomaterials for Hemostasis.Annual review of biomedical engineering · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

W Brad HubbardBiomedical Engineering and Mechanics, Virginia Tech, Blacksburg, VA, USA.ORCID 0000-0001-7018-0148
Margaret Lashof-SullivanDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.
Shaylen GreenbergTranslational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, USA.
Carly NorrisBiomedical Engineering and Mechanics, Virginia Tech, Blacksburg, VA, USA.
Joseph EckBiomedical Engineering and Mechanics, Virginia Tech, Blacksburg, VA, USA.
Erin LavikDepartment of Chemical, Biochemical and Environmental Engineering, University of Maryland- Baltimore County, Baltimore, MD, USA. elavik@umbc.edu.
Pamela VandeVordBiomedical Engineering and Mechanics, Virginia Tech, Blacksburg, VA, USA. pvord@vt.edu.

Funding

U.S. Department of Defense (DOD) W81XWH-11-1-0014U.S. Department of Health & Human Services | National Institutes of Health (NIH) DP20D007338
6 · The paper itself

Abstract

Explosions account for 79% of combat related injuries and often lead to polytrauma, a majority of which include blast-induced traumatic brain injuries (bTBI). These injuries lead to internal bleeding in multiple organs and, in the case of bTBI, long term neurological deficits. Currently, there are no treatments for internal bleeding beyond fluid resuscitation and surgery. There is also a dearth of treatments for TBI. We have developed a novel approach using hemostatic nanoparticles that encapsulate an anti-inflammatory, dexamethasone, to stop the bleeding and reduce inflammation after injury. We hypothesize that this will improve not only survival but long term functional outcomes after blast polytrauma. Poly(lactic-co-glycolic acid) hemostatic nanoparticles encapsulating dexamethasone (hDNPs) were fabricated and tested following injury along with appropriate controls. Rats were exposed to a single blast wave using an Advanced Blast Simulator, inducing primary blast lung and bTBI. Survival was elevated in the hDNPs group compared to controls. Elevated anxiety parameters were found in the controls, compared to hDNPs. Histological analysis indicated that apoptosis and blood-brain barrier disruption in the amygdala were significantly increased in the controls compared to the hDNPs and sham groups. Immediate intervention is crucial to mitigate injury mechanisms that contribute to emotional deficits.

Indexed as

AnimalsAnxietyBehavior, AnimalBlast InjuriesBrain InjuriesDexamethasoneDisease Models, AnimalDrug CarriersExplosionsHemostaticsHumansInjections, IntravenousMaleMultiple TraumaNanoparticlesPolylactic Acid-Polyglycolic Acid CopolymerDexamethasoneDrug CarriersHemostaticsPolylactic Acid-Polyglycolic Acid Copolymer

Identifiers

PMID30006635
PMCPMC6045585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.